Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress, Informa Connect, recently presented significant findings at the 84th American Diabetes Association (ADA) Scientific Sessions.
The poster abstract, titled “A CME Webcast Series’ Impact on Clinicians’ Knowledge and Competence of Long-Term Obesity Management in Patients with Type 2 Diabetes,” shared outcomes from a CME webcast series jointly provided by the Postgraduate Institute for Medicine and Tarsus Cardio (dba Cardiometabolic Health Congress) and funded by Lilly USA, LLC.
"For the past 19 years, the Cardiometabolic Health Congress has been dedicated to equipping healthcare professionals with the latest advancements in cardiometabolic health. It is a pleasure to witness so many studies and discussions at the ADA focused on enhancing cardiometabolic health and improving patient outcomes."
Key Findings and Impacts:
Improved Knowledge: Healthcare professionals showed an enhanced understanding of newer weight management therapies, including their safety and efficacy. Knowledge about new weight management therapies mechanism of action (MOA) increased from 34% pre-test to 91% post-test. Knowledge of key aspects of glycemic management increased from 26% pre-test to 85% post-test.
Treatment Competency: Participants demonstrated increased competency in identifying appropriate treatment options and implementing shared decision-making models. Competence in selecting treatments for long-term obesity management rose from 43% pre-test to 95% post-test.
Practice Changes: 75% of participants plan to make changes in their practice, including:
Using patient-first language
Discussing lifestyle modifications
Utilizing weight-neutral or weight-lowering medications for glycemic control
Encouraging patients to track exercise and diet
Participant Satisfaction: 91% of participants were satisfied with the activity and met the learning objectives.
Challenges Identified:
Underdiagnosis and inadequate treatment of overweight and obesity in type 2 diabetes patients
Difficulty in achieving long-term weight loss and maintenance
Reluctance to use medications for weight management and cardiometabolic risk reduction
Underutilization of treatments beyond lifestyle counseling
Educational Activities Timeline:
November 2022: Launch of enduring 6-part webcast series
March 2023: Social media campaign #ObesityinT2D launched
Learner Demographics:
7,867 activity page visits
3,538 learners
3,310 evaluations
Conclusions:
Learners are now more knowledgeable about recent clinical trial data and emerging therapies for long-term weight management.
There is a notable increase in competency regarding treatment options, including shared decision-making to increase the success of long-term weight loss.
CMHC is proud to share that the study findings have been published in the American Diabetes Association (ADA) Diabetes Journal and can be found here.
Transforming Care Through Ongoing Education
For more updates and continuing medical education, healthcare professionals are encouraged to attend the upcoming 19th Annual CMHC meeting in Boston, MA (October 17-19).
The Diabetes Track will feature:
“Precision Medicine in Diabetes” by Jose C. Florez, MD, PhD
“Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients” by Jay H. Shubrook, DO, FAAFP, FACOFP
“CGM in People Without Diabetes and CVD Risk” by Grazia Aleppo, MD, FACE, FACP
A panel discussion on challenging diabetes management cases moderated by Anne L. Peters, MD
To learn more and register for the 19th Annual CMHC, click here.
